Breakthrough T1D
66 meetings with public office holders, Jul 17, 2025 to Jul 30, 2026.
355 meetings on record since 2009, their first on record.
Meetings over time
- Jul 2025: 1 meeting, with Jade Mallette, Shahad Khalladi
- Aug 2025: 1 meeting, with Maggie Chi
- Sep 2025: 3 meetings, with Karim Bardeesy, Élisabeth Brière, Chris d'Entremont, Karen Sorensen, Manuela Tomic
- Oct 2025: 0 meetings
- Nov 2025: 2 meetings, with Maggie Chi, Mona Fortier
- Dec 2025: 2 meetings, with Anthony Lostracco, Rodrigue Burnett, Anthony Sabourin, Sonia Sidhu
- Jan 2026: 2 meetings, with Anthony Lostracco, Anthony Sabourin
- Feb 2026: 2 meetings, with Sonia Sidhu, Karen Sorensen
- Mar 2026: 0 meetings
- Apr 2026: 3 meetings, with Anita Anand, Ben Carr, Maggie Chi, Raquel Dancho, Sean Fraser
- May 2026: 36 meetings, with Justine Frame, Jibril Hussein, Wade Grant, Ellis Ross, Dan Mazier
- Jun 2026: 4 meetings, with Manuela Tomic, Chris Malette, Justine Frame, Élisabeth Brière
- Jul 2026: 10 meetings, with Raquel Dancho, Paul Moen, Robert Oliphant, Anna Roberts, Ritu Banerjee
Hover or focus a month to see who was met.
What they lobby about
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
- Anthony Lostracco
- Jibril Hussein
- Justine Frame
- Karen Sorensen
- Anthony Sabourin
- Manuela Tomic
- Annahat Kochhar
- Benoit Leduc
- Brian O’Leary
- Celia Lourenco
- Colin Deacon
- Dan Charbonneau
- Darcy Ross
- Elizabeth Wong
- Gigi Osler
- Jack Power
- Jade Mallette
- Jane MacAdam
The 40 most-met of 70 people named in these filings.
House of Commons (51) · Health Canada (HC) (16) · Senate of Canada (13) · Innovation, Science and Economic Development Canada (ISED) (7) · Treasury Board Of Canada Secretariat (TBS) (2) · Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC) (1)
In their own words
- Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research towards a cure for type 1 diabetes
- Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting patient choice.
- Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.